Chemical modification of β-glucocerebrosidase inhibitor N -octyl-β-valienamine: synthesis and biological evaluation of N -alkanoyl and N -alkyl derivatives
- 1 October 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 6 (10) , 1955-1962
- https://doi.org/10.1016/s0968-0896(98)00143-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Synthesis and biological evaluation of four stereoisomers of PDMP-analogue, N-(2-decylamino-3-hydroxy-3-phenylprop-1-yl)-β-valienamine, and related compoundsBioorganic & Medicinal Chemistry Letters, 1997
- Synthesis of potent β-D-glucocerebrosidase inhibitors: N-alkyl-β-valienaminesBioorganic & Medicinal Chemistry Letters, 1996
- Glucosylceramide synthetase inhibitor, d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cellsCancer Letters, 1996
- Pseudosugars, 35. Synthesis of glycosylceramide analogs composed of imino‐linked unsaturated 5a‐carbaglycosyl residues: Potent and specific gluco‐ and galactocerebrosidase inhibitorsEuropean Journal of Organic Chemistry, 1995
- Pseudosugars, 34. Synthesis of 5a‐carba‐β‐D‐glycosylceramide analogs linked by imino, ether and sulfide bridgesEuropean Journal of Organic Chemistry, 1995
- Alternative synthesis and enzyme-inhibitory activity of methyl 1′-epiacarviosin and its 6-hydroxy analogCarbohydrate Research, 1992
- Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cellsJournal of Cellular Physiology, 1989
- Gaucher Type 1 (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrateClinica Chimica Acta; International Journal of Clinical Chemistry, 1982